What is the expense ratio for GNOM?

GNOM (Global X Genomics & Biotech ETF) has an annual expense ratio of 0.50%, issued by Global X. This means for every $10,000 invested, you pay $50 per year in fund fees.

Is GNOM a good ETF to buy?

Global X Genomics & Biotech ETF suits investors seeking exposure to Thematic & Innovation. View the full analysis including performance score, tracking quality, diversification, and macro regime fit on Fisclear.

GNOM — Global X Genomics & Biotech ETF | Fisclear

Today

-1.61%

3 Month

+5.40%

YTD

+4.62%

1 Year

+44.18%

Price Chart

251 trading days · Use "Compare" tab to overlay other ETFs + regimes

Price History

Compare — add ETFs, toggle regime overlay

Base 100 = start of period

GNOM

Technical Analysis

Technical Signals

Daily closes · 1-year data

ETF Structural Score

ETF Score evaluates fund wrapper quality, historical performance, and macro regime fit. Not financial advice.

Key Statistics

AUM

—

Expense Ratio

0.50%

Trailing Yield

—

Equity

—

Fixed Income

—

Issuer

Global X

vs S&P 500 (SPY) — 1 Year

Beta

1.29

GNOM moves roughly in line with the S&P 500. Beta near 1 = broad market tracking.

Correlation to SPY

0.58

Low correlation — moves more independently. Adding this alongside SPY reduces portfolio volatility.

Annualised Volatility

27.0%

Standard deviation of daily returns annualised. S&P 500 long-run avg ≈ 15%. At 27%, GNOM is significantly more volatile than the broad market.

Relative Performance — GNOM vs SPY (base 100)

Base: 100 (day 1)

GNOM: 144.2

SPY: 124.7

Alpha: +19.5 (outperformed)

About GNOM

Genomics biotechnology — CRISPR, cell and gene therapies.

Macro Regime Alignment

Historical analysis of which macro regimes have favoured GNOM. Based on the regime's characteristic interest rate environment, growth conditions, and sector rotation patterns.

Liquidity Boom

QE · ZIRP · Fed BS ↑

The Fed is printing money and rates are near zero. Every asset inflates as cheap liquidity floods markets. The 'don't fight the Fed' regime — risk assets outperform.

Rate Cut Anticipation

2Y yield ↓ · Pivot approaching

Growth is slowing and the market is pricing in rate cuts. Bonds rally ahead of the Fed. Gold shines as real rates fall. Risk assets begin recovering on the expectation of easier money.

Current regime: Inflationary Boom — this ETF is not historically among the strongest performers in the current macro environment. Consider checking which ETFs are regime-aligned on the ETF Explorer.

Disclaimer: All data sourced from Yahoo Finance and is for informational purposes only. Holdings, sector weights, and AUM update daily but may lag official fund disclosures. Performance figures are price-based and do not include dividends. Regime alignment reflects historical observations and does not guarantee future returns. Nothing on this page constitutes investment advice. Always consult a qualified financial adviser before making investment decisions.